跳至主要内容
临床试验/CTRI/2020/03/023890
CTRI/2020/03/023890尚未招募2 期

A randomized open labelled comparative clinical study to evaluate the efficacy of Virechana with and without Snehapurva Rukshana in the management of Dyslipidemia

Dr Reeny Ravina Dias0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • subjects diagnosed with dyslipidemia with any of the serum lipid levels,
  • S. Cholesterol - 200-500mg/dl
  • S. Triglycerides - 150-400mg/dl
  • HDL - <40mg/dl
  • LDL - 130-400mg/dl
  • Subjects fit for Snehapana, Swedana, Udwartana and Virechana
  • VLDL - 40-200mg/dl

排除标准

  • Subjects unfit for snehapana, swedana, udwartana and virechana.
  • Subjects with type 1 diabetes, uncontrolled diabetes mellitus, uncontrolled hypertension, cardiovascular diseases
  • Dyslipidemia due to endocrine or renal pathologies
  • Dyslipidemia due to drugs e.g. glucocorticoids etc
  • Pregnant and lactating women

研究者

发起方
Dr Reeny Ravina Dias

相似试验